Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) [Yahoo! Finance]
Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $56.00 price target on the stock, up from $54.00.
Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by HC Wainwright. They now have a $60.00 price target on the stock.
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript [Seeking Alpha]
Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037 [Yahoo! Finance]